Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

BioAegis Therapeutics Initiates Trial of Its Inflammation Regulator for COVID-19 Treatment

americanpharmaceuticalreviewAugust 07, 2020

Tag: BioAegis Therapeutics , COVID-19 , pneumonia

PharmaSources Customer Service